2025 Distribution Management Conference and Expo | Healthcare Distribution Alliance | HDA

Back to upcoming events

2025 Distribution Management Conference and Expo

March 2-5, 2025 | JW Marriott Tampa Water Street

39

Days
00

Hours
12

Minutes

1:00 PM - 7:30 PM H.B. Plant and Ybor Ballroom Prefunction

Registration
1:00 PM - 5:00 PM Tampa Bay 5-9

Exhibitor Setup
5:00 PM - 6:00 PM Anchor & Brine (Marriott Tampa Water Street)

VIP Reception (Invitation Only)
6:00 PM - 7:30 PM Anchor & Brine (Marriott Tampa Water Street)

Welcome Reception

7:00 AM - 6:15 PM H.B. Plant and Ybor Ballroom Prefunction

Registration
Sponsors
8:00 AM - 9:30 AM H.B. Plant A-F

Opening General Session
Speakers
- Chester "Chip" Davis, Jr.
  
  President and Chief Executive Officer
  
  Healthcare Distribution Alliance
8:20 AM - 8:30 AM H.B. Plant A-F

Distribution Management Award Presentation
Description

Shaun Boothe will take us on a trip around the world to celebrate the powerful life lessons of iconic figures. Shaun uses live music and storytelling to inspire growth, resilience, leadership and a sense of purpose. It’s more than a keynote — it’s an experience that will leave you motivated to embrace your own story and take bold steps toward your goals.
Speakers
- Shaun Boothe
  
  Creator
  
  The Unauthorized Biography Series
9:30 AM - 10:00 AM Tampa Bay 5-9

Expo Grand Opening and Morning Break
10:00 AM - 11:00 AM

Concurrent Education Sessions A
Description

This session will provide an opportunity to hear directly from the Agency on guidance documents, hear them give a brief overview of the DSCSA, highlight recent guidances and other efforts, and discuss expectations for the pharmaceutical supply chain efforts during the stabilization period.
Sponsors
Speakers
- Abha Kundi
  
  Team Lead in the Office of Drug Security, Integrity and Response
  
  Office of Compliance, Center for Drug Evaluation and Research, U.S. Food and Drug Administration
Speakers
- Joe DePinto
  
  Head of Cell, Gene and Advanced Therapies
  
  McKesson Corporation
10:00 AM - 11:00 AM Ybor V

Security Session
11:00 AM - 11:15 AM

Movement Break
11:15 AM - 12:15 PM

Concurrent Education Sessions B
Description

Distribution experts will share their most recent experiences as trading partners work toward the end of the May manufacturer exemption phase and beyond. Presenters will share their accomplishments and challenges from the past several months, while highlighting areas for improvement.
Sponsors
Speakers
- Ashley Y. DeFlice
  
  Senior Regulatory Affairs Specialist
  
  Henry Schein, Inc.
- Libby Dewey
  
  Manager, DSCSA
  
  Cardinal Health, Inc.
- Elizabeth A. Gallenagh
  
  General Counsel and Senior Vice President, Supply Chain Integrity
  
  Healthcare Distribution Alliance
- Jessica Richards Hosgood
  
  VP of Pharmacy Operations & Compliance
  
  Capital Wholesale Drug Co.
- Peggy Yena
  
  VP, Quality & Regulatory Affairs
  
  BioCare, Inc.
Description

Learn about the range of policies legislators are addressing at the start of the 119th Congress including: drug shortages, prescription drug pricing and how the new administration will impact those discussions. Bring your political knowledge, win fun prizes, and impress your peers!
Speakers
- Kristen L. Freitas
  
  SVP, Federal Government Affairs and Alliance Development
  
  Healthcare Distribution Alliance
11:15 AM - 12:15 PM Ybor IV

Contracts and Chargebacks Roundtables
Sponsors
Speakers
- Meriel Martinez
  
  Director of Programs & Inclusion
  
  NONPROFIT LEADERSHIP CENTER
12:15 PM - 1:15 PM Tampa Bay 1-4

General Luncheon
1:15 PM - 1:45 PM Tampa Bay 5-9

Expo and Dessert Break
2:00 PM - 3:00 PM

Concurrent Education Sessions C
Description

This session will focus on how to apply the recently published GS1 EPCIS exception handling addendum use cases with more commonly occurring exceptions. Speakers will also address such challenges as determining trading partner exemption eligibility, staff technical qualification needs and audit concerns.
Sponsors
Speakers
- Gregg A. Gorniak
  
  VP - Manufacturer Operations & Data Services | Secure Supply Chain Lead
  
  Cencora, Inc.
- Bruce Harold
  
  Director of EDI
  
  KeySource
- Scott A. Mooney
  
  Vice President Distribution Operations, Traceability
  
  McKesson Corporation
- Tim Stearns
  
  Senior Director, Industry Relations
  
  Healthcare Distribution Alliance
Description

Gain critical insights into the latest legislative and regulatory developments impacting the wholesale distribution
industry in the states. This session will cover key state-level actions on healthcare affordability, prescription drug pricing, state licensure and controlled substance regulations, among other pressing issues. Join us for an in-depth analysis of the state policies shaping the landscape for distributors today.
Speakers
- Leah D. Lindahl
  
  Vice President, State Government Affairs
  
  Healthcare Distribution Alliance
2:00 PM - 3:00 PM Ybor IV

Specialty Distribution Session
Description

This session will explore the government's recent response to several high-impact, high-profile cyberattacks to provide
healthcare distributors valuable insight into cyber resilience and risk management. Attendees will learn how various critical infrastructure voluntary programs and public-private partnerships are addressing cyber threats, among other issues.
Speakers
- Jenny Stone
  
  Founder/CEO
  
  Partner Forces
3:00 PM - 3:15 PM

Movement Break
3:15 PM - 4:15 PM

Concurrent Education Sessions D
Sponsors
Description

This session will explore recent changes in state and federal reimbursement policy and what impact they have on the pharmaceutical supply chain.
Speakers
- Kala Shankle
  
  Vice President, Regulatory Affairs
  
  Healthcare Distribution Alliance
- Stephanie Trunk
  
  Partner
  
  ArentFox Schiff LLP
Description

Launching a specialty drug is no easy task, filled with complexities. With the increase in specialty drugs in the
pipeline, it is more important than ever to understand the go-to-market strategies that will ultimately translate into positive results for patients. A panel of commercialization and operational experts will share the “dos and don’ts” of taking a specialty drug to market, using real world examples. Participants will walk away with a checklist of the various workstreams that need to be proactively planned to ensure the specialty drug makes it to the patient in the most efficient and economical way.
Speakers
- Lisa D. Arthurs
  
  Vice President, Trade
  
  Two Labs Pharma Services - An Envision Company
- Michael Rowe
  
  Director, DSCSA/Serialization Services
  
  Two Labs Pharma Services - An Envision Company
Description

We're living through an era of considerable change. But all too often we focus on what's driving the change rather than our individual and collective responses to the change itself. Did you know our learned responses and approaches to change vary by generation? Leading multi-generational teams through change can be all the more challenging without
a greater understanding of these differences. In this presentation, you will hear fascinating insights on how to leverage and manage multi-generational teams in a time of change. Learn interesting trends data and valuable team-building
strategies so you are ready for whatever change comes next!
Sponsors
4:15 PM - 6:15 PM Tampa Bay 5-9

Expo Reception and Raffle

7:00 AM - 6:15 PM H.B. Plant and Ybor Ballroom Prefunction

Registration
7:00 AM - 7:45 AM Tampa Bay 1-4

General Breakfast
8:15 AM - 9:30 AM H.B. Plant A-F

Morning General Session
Description

In today's fast-paced world, professionals frequently find themselves operating on autopilot, particularly when it comes to choices that can have a profound impact on relationships with customers and peers. Truly successful organizations are those that empower their employees to make deliberate and considerate choices in all aspects of their daily operations. With hundreds of decisions needing to be made every day, how do companies help their employees make the right decisions?
Sylvie DiGiusto will take attendees on a mind-bending journey—enhanced by cutting-edge 3D technology— to show how “The Power of Choice” can be harnessed to create truly transformative experiences for your clients and employees.
Speakers
- Sylvie DiGiusto
  
  Former Corporate Leader & Executive Coach
  
  Emotional Intelligence Speaker
9:30 AM - 10:00 AM Tampa Bay 5-9

Expo and Morning Break
10:00 AM - 11:00 AM

Concurrent Education Sessions E
Description

Regulators representing several state Boards of Pharmacy will voice their perspectives on enforcement of the DSCSA as final implementation goes into effect over the next year. Regulators will address the challenges with enforcement, consider best practices for industry, and highlight the importance of communication and partnership with regulators and industry throughout 2025 and beyond.
Sponsors
Speakers
- Nicki Chopski
  
  Executive Officer
  
  Idaho Board of Pharmacy
- Jeremy Evans
  
  Drug Administrator, Food & Drug Protection Division
  
  North Carolina Department of Agriculture & Consumer Services
- John Kirtley
  
  Executive Director
  
  Arkansas State Board of Pharmacy
- Kala Shankle
  
  Vice President, Regulatory Affairs
  
  Healthcare Distribution Alliance
Description

Interact with DEA and discuss current topics in controlled substances regulation.
Sponsors
Speakers
- Thomas W. Prevoznik
  
  Assistant Administrator, Diversion Control Division
  
  U.S. Drug Enforcement Administration (DEA)
- Matthew Strait
  
  Deputy Assistant Administrator
  
  U.S. Drug Enforcement Administration (DEA)
10:00 AM - 11:00 AM Ybor IV

340B Best Practices for Distributors/Manufacturers
11:00 AM - 11:15 AM

Movement Break
11:15 AM - 12:15 PM

Concurrent Education Sessions F
Description

The Verification Router Service Provider Network (VRS PN) is an HDA service offering that provides a structure for maintaining interoperability among its members, in coordination with industry stakeholders, to fulfill DSCSA requirements. This session will cover the VRS PN’s progress on establishing governance through collaboration and policy development. It will cover lessons learned and activities driving industry adoption, while highlighting the benefits of stakeholder engagement.
Sponsors
Speakers
- Blair Korman
  
  Sr. Director, Digital Identification & Traceability
  
  Johnson & Johnson Supply Chain
- Maryann Nelson
  
  Regulatory Manager
  
  Cardinal Health, Inc.
- Jaidalyn Rand
  
  Director, Industry Relations
  
  Healthcare Distribution Alliance
Description

A panel of experts will discuss "suspicious orders" monitoring and other legal issues in the evolving controlled substances regulatory environment.
Speakers
- John A. Gilbert
  
  Director
  
  Hyman, Phelps, and McNamara, P.C.
- Karla Palmer
  
  Director
  
  Hyman, Phelps, and McNamara, P.C.
Description

This session will provide an update on current guidance and initiatives related to the 340B Drug Pricing Program as well as top-of-mind operational issues for distributors and manufacturers.
Speakers
- Christopher Shain
  
  Vice President, Supply Chain Advisory Services, Pharmaceutical Solutions and Services
  
  McKesson Corporation
Speakers
- Reggie Romain
  
  Talent Research Associate Manager
  
  Accenture
12:15 PM - 1:15 PM Tampa Bay 1-4

General Luncheon
1:15 PM - 1:45 PM Tampa Bay 5-9

Expo and Dessert Break
2:00 PM - 3:00 PM

Concurrent Education Sessions G
Description

An industry panel will assess how the NDC/barcode change might impact DSCSA implementation compliance programs — and which systems and processes will need modifications.
Sponsors
Speakers
- Craig Little
  
  Senior Systems Developer
  
  Value Drug Company
- David G. Mason
  
  Supply Chain Compliance and Serialization Lead
  
  Novartis Pharmaceuticals Corporation
- Andrew Meyer
  
  Director, Global Standards
  
  GS1 US
- Leon Nevers
  
  Senior Director, Procurement and Business Development
  
  H-E-B
- Tim Stearns
  
  Senior Director, Industry Relations
  
  Healthcare Distribution Alliance
Description

FDA communicated widely to industry that supply chain trading partners can be held responsible for ensuring that products meet manufacturing quality attributes and that adequate supplier qualification procedures must be in place. Learn about the agency’s recent regulatory actions and statements concerning responsibilities to ensure manufacturing quality in the pharmaceutical supply chain — and how these changes can relate to wholesale drug distributors.
Speakers
- Kala Shankle
  
  Vice President, Regulatory Affairs
  
  Healthcare Distribution Alliance
2:00 PM - 3:00 PM Ybor IV

Specialty Distribution Session
Description

Join us for an illuminating session poised to empower and equip advocates with the tools necessary to drive meaningful change. Crafted for those eager to delve into effective advocacy, this session will explore grassroots engagement and demystify the intricacies of political action committees (PACs). Participants will learn the art of tailoring messages to resonate with lawmakers — and ensure maximum impact in legislative arenas. Additionally, gain invaluable firsthand insights through an interview with a former Capitol Hill staffer, who will provide unique perspectives and strategies for navigating the political landscape.
Speakers
- Kristen L. Freitas
  
  SVP, Federal Government Affairs and Alliance Development
  
  Healthcare Distribution Alliance
3:00 PM - 3:15 PM

Movement Break
3:15 PM - 4:15 PM H.B. Plant A-F

Afternoon General Session
Description

Specializing in analyzing information from IQVIA’s premier sales, prescription, promotional and medical databases, Doug Long will take a first look at the latest industry data and emerging market trends for branded and generic pharmaceutical and specialty product sales. Long will offer his perspective on a range of vital pharmaceutical topics, including global market trends, industry forecasts, research and development, marketing practices, blockbuster drugs, patent expirations and generic trends, biotechnology and more. He also will analyze how emerging trends will affect strategic business plans in the coming year and beyond.
Speakers
- Scott Biggs
  
  Director, Supplier Services
  
  IQVIA
- Douglas M. Long
  
  Vice President, Industry Relations
  
  IQVIA
4:15 PM - 6:15 PM Tampa Bay 5-9

Networking Reception and Expo Raffle
6:15 PM - 8:00 PM Tampa Bay 5-9

Exhibitor Move-out

8:00 AM - 10:00 AM H.B. Plant and Ybor Ballroom Prefunction

Registration
8:00 AM - 9:00 AM H.B. Plant A-F

General Breakfast
9:00 AM - 11:00 AM H.B. Plant A-F

Closing General Session
Description

Special Agent Dan Burke will provide an inside look at how the FDA’s Office of Criminal Investigations investigates the illicit pharmaceutical supply chain. Agent Burke will detail recent criminal cases involving the illegal sale and
distribution of pharmaceutical drugs to U.S. consumers and physicians from foreign sources and discuss some of the challenges facing the legitimate supply chain.
Speakers
- Daniel Burke
  
  Chief, Investigative Services Division
  
  U.S. Food and Drug Administration
Description

Trust is in crisis, and earning trust has never been more imperative than it is now. Trust solves risk problems, improves
culture and increases innovation to prepare for an uncertain future. Nonverbal communication expert and trust strategist, Pamela Barnum, will bring her decades of experience as an undercover drug enforcement agent, prosecuting attorney and beyond to help attendees master the five qualities that set trusted leaders apart from the rest.
Speakers
- Pamela Barnum
  
  Former Undercover Police Officer & Federal Prosecutor
  
  Body Language & Negotiations Expert
11:00 AM - 12:00 PM

Conference Adjournment

Registration and Hotel Information

Genesis Argueta
Sponsorship Opportunities

Lisa Kanfer
Exhibit and Membership Opportunities

Michelle Leslie
Conference Schedule, Speaker Information, and Education Content

Subrina Ghorashi